France considers single vaccine dose for COVID-19 survivors

The COVID-19 vaccines from Pfizer-BioNTech and Moderna require two doses. But, new research suggests survivors of the illness only require one dose.

Crystal Goomansingh explains why France is considering adopting this strategy.

As coronavirus vaccines continue to roll out to vulnerable populations across Canada, health officials are looking at data about the effectiveness of a single dose in preventing COVID-19 illness in the country too.

A new letter by two Canadian experts published in the New England Journal of Medicine (NEJM) last week stated that with a 92.6 per cent efficacy, the first dose of the Pfizer vaccine was “highly protective.”

For more info, please go to https://globalnews.ca/news/7660292/coronavirus-vaccine-single-dose/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Vaccines #Coronavirus #France #GlobalNews